Summary of project PR001390
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001390. The data can be accessed directly via it's Project DOI: 10.21228/M82117 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Project ID: | PR001390 |
Project DOI: | doi: 10.21228/M82117 |
Project Title: | Individualized exercise intervention for people with multiple myeloma improves quality of life in a randomized controlled trial |
Project Type: | MS untargeted metabolomics analysis |
Project Summary: | Although new treatments have improved survival for multiple myeloma (MM), quality of life remains poor for people with this incurable cancer. We conducted a multi-site randomized, waitlist-controlled trial of an individualized exercise program for people at all stages of MM (n=60). Compared to the waitlist control group, participants of the 12-week intervention had significant improvement in health-related quality of life, mediated through improved MM symptoms, cardiorespiratory fitness and bone pain, with were mostly maintained at follow-up (up to 12 months). Exploratory plasma metabolomics and lipidomics was conducted to delineate molecular mechanisms and biomarkers |
Institute: | QIMR Berghofer Medical Research Institute |
Laboratory: | Precision & Systems Biomedicine |
Last Name: | Stoll |
First Name: | Thomas |
Address: | 300 Herston Road, Herston, Queensland, 4006, Australia |
Email: | thomas.stoll@qimrberghofer.edu.au |
Phone: | +61 7 3845 3992 |
Summary of all studies in project PR001390
Study ID | Study Title | Species | Institute | Analysis(* : Contains Untargted data) | Release Date | Version | Samples | Download(* : Contains raw data) |
---|---|---|---|---|---|---|---|---|
ST002183 | Individualized exercise intervention for people with multiple myeloma improves quality of life in a randomized controlled trial | Homo sapiens | QIMR Berghofer Medical Research Institute | MS* | 2024-02-05 | 1 | 180 | Uploaded data (27.4G)* |